[A case of advanced sigmoid colon cancer successfully treated with multimodality therapy].

Naoki Nishie, Ryo Inada, Yoshiko Mori, Yoshitaka Kondo, Futoshi Uno, Takeshi Nagasaka, Masashi Utsumi, Yuzo Umeda, Hiroshi Sadamori, Takahito Yagi, Toshiyoshi Fujiwara

Research output: Contribution to journalArticlepeer-review


A 61-year-old man underwent sigmoidectomy with partial cystectomy for advanced sigmoid colon cancer with unresectable multiple liver metastases at the Okayama University Hospital in June 2006. Pathological examination revealed moderately differentiated adenocarcinoma, pStage IV( pSI[ bladder], pN0, pH2, pP0, pM0), as per the Japanese Classification of Colorectal Carcinoma, seventh edition. The patient underwent systematic chemotherapy with irinotecan, 5-fluorouraci( l 5-FU), and folinic acid( FOLFIRI) and oxaliplatin, Leucovorin, and 5-FU( mFOLFOX6) for 13 months. In July 2007, hepatectomy was performed as the liver metastatic lesions had shrunk to a resectable size. Follow-up computed tomography (CT) in November 2009 revealed recurrence in the liver and lung. Subsequently, lateral segmentectomy was performed for the recurrent liver lesions, and radiofrequency ablation( RFA) was performed for the lung lesions. After having undergone RFA, the patient is doing well without any re-recurrence. We encountered a patient with advanced sigmoid colon cancer who was successfully treated with multimodality therapy. For patients with advanced or recurrent colorectal cancers, curative resection can lead to a good prognosis; however, in most patients, it is difficult to achieve curative resection by upfront surgery. Multimodality therapy could facilitate curative resection, thereby resulting in a good prognosis.

Original languageEnglish
Pages (from-to)1959-1961
Number of pages3
JournalUnknown Journal
Issue number12
Publication statusPublished - Nov 2013
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of '[A case of advanced sigmoid colon cancer successfully treated with multimodality therapy].'. Together they form a unique fingerprint.

Cite this